PharmaBXL

Active

Private limited companyfounded 20223 yrs activeZavelput 17, 1000 Brussel, BelgiumKBO/BCE: BE 0795.508.480

The computed 12-month bankruptcy probability of PharmaBXL is 1.6% (moderate). The 2024 annual accounts show equity of €382k and a net result of €241k. Its solvency ranks better than 39% of 9517 sector peers (fiscal year 2024). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.

Watch Print / PDF

Checked score

Score 2024

67 / 100

Healthy

The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.

Axes · tick = 2023

Profitability99▲+99

Solvency63▲+13

Growth78

Track record94

Bankruptcy probability, 12 months

1.6% Moderate

0%0.5%1.5%4%10%≥ 25%

Credit up to €25k at 30 days acceptable

Liquidity ample (current ratio 5.93 against 28.7 in 2023; short-term debt: 15.7% and cash: 3.7% of total assets), but 61.6% of the assets are financed with debt.

How do we compute the score and the probability?

Credit advice for your own amount and term

Signals

Five signals. The signal on the left, the evidence on the right.

−lowers risk+raises risk○neutral

Limited track record

This company has not been active as long as an established one and statistically fails somewhat more often.

KBO · incorporation date

Age against the risk zone

Higher-failure-rate region

In this region companies fail more often than in the rest of the country.

KBO · registered office

Lower-failure-rate sector

In this sector companies fail less often than the Belgian average.

Gazette · bankruptcies per sector, NACE 82

Relative position

BE, all sectors

reference

Sector 82

lower

← fewer bankruptcies more bankruptcies →

Filed after the deadline

The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 30-09-2025, 61 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.

NBB · 2 filings

Deviation from the deadline

2025

not confirmed

2024

61 d late

2023

26 d late

← before the deadline after the deadline →

No strike-offs in the KBO publications

We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

KBO publications · our coverage

Financials · fiscal year 2024, micro schema

Equity

€382k▲ 171%

2023 · €141k

2023: €141k

2023 → 2024

Total assets

€994k▲ 74.1%

2023 · €571k

2023: €571k

2023 → 2024

Net result

€241k

2023 · €-269k

2023: €-269k

2023 → 2024

Working capital

€768k▲ 39.8%

2023 · €549k

2023: €549k

2023 → 2024

Multi-year overview

Every figure with its change against the year before

▲ rise ▼ fall

Line20232024Trend

Equity€141k-€382k▲ 171%

Operating result€-270k-€250k

Net result€-269k-€241k

Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.

Result per fiscal year

Operating resultNet result

The operating result returns to profit in 2024: €250k after a loss of €270k in 2023.

Balance-sheet composition

2024 in colour, 2023 as the grey bar beneath

Assets €994k

93.0%

Fixed assets €70k▲ 3,778%

Current assets €924k▲ 62.4%

Equity and liabilities €994k

38.4%

61.6%

Equity €382k▲ 171%

Debt €612k▲ 42.3%

The debt ratio falls from 75.3% to 61.6%. Equity and debt are higher.

Key figures and ratios

2024 value · change against 2023

EBITDA

€267k

Cash flow

€258k

Solvency

38.4%▲

2023 · 24.7%

Current ratio

5.93▼

2023 · 28.70

Quick ratio

5.93▼

2023 · 28.70

Debt / equity

1.60▼

2023 · 3.05

ROE

63.1%▲

2023 · -191.0%

ROA

24.3%▲

2023 · -47.1%

Interest coverage

29.75

Debt

€612k▲

2023 · €430k

Debt ≤ 1 year

€156k▲

2023 · €20k

Debt > 1 year

€409k=

2023 · €409k

Staff costs

€169k▲

2023 · €4k

Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.

Filed annual accounts

As filed with the NBB · 2024 against 2023

Balance sheet Code20232024

Assets

Total assets20/58€571k€994k▲

Fixed assets21/28€2k€70k▲

Intangible fixed assets21-€68k

Financial fixed assets28€2k€2k=

Current assets29/58€569k€924k▲

Amounts receivable within one year40/41€448k€882k▲

Trade receivables40€363€273k▲

Other amounts receivable41€447k€609k▲

Cash at bank and in hand54/58€106k€37k▼

Deferred charges and accrued income490/1€15k€5k▼

Equity and liabilities

Total equity and liabilities10/49€571k€994k▲

Equity10/15€141k€382k▲

Contributions10/11€410k€410k=

Profit (loss) carried forward14€-269k€-28k▲

Amounts payable17/49€430k€612k▲

Amounts payable after more than one year17€409k€409k=

Financial debts170/4€409k€409k=

Amounts payable within one year42/48€20k€156k▲

Trade debts44€19k€50k▲

Suppliers440/4€19k€50k▲

Taxes, remuneration and social security45€1k€61k▲

Taxes450/3€551€4k▲

Remuneration and social security454/9€524€57k▲

Other amounts payable47/48-€44k

Accrued charges and deferred income492/3€709€46k▲

Income statement Code20232024

Non-recurring operating income76A-€243k

Remuneration, social security and pensions62€4k€169k▲

Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630-€17k

Other operating charges640/8€1k€387▼

Gross operating margin9900€-265k€436k▲

Operating profit (loss)9901€-270k€250k▲

Financial income75/76B€1k€66▼

Recurring financial income75€1k€66▼

Financial charges65/66B€98€9k▲

Recurring financial charges65€98€9k▲

Profit (loss) for the period before taxes9903€-269k€241k▲

Profit (loss) for the period9904€-269k€241k▲

Profit (loss) for the period to be appropriated9905€-269k€241k▲

Appropriation of the result

Profit (loss) to be appropriated9906€-269k€-28k▲

Profit (loss) brought forward from the previous period14P-€-269k

The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

All 4Financial 2Filings 2

2025

30-09

NBB filing Annual accounts filed

fiscal year 2024 · micro schema · 61 days late

2024

31-12

Financial Back to profitnet €241k

Net result €241k after one loss-making year.

31-12

Financial Equity above €200kEq €382k ▲171%

Equity rises from €141k to €382k.

26-08

NBB filing Annual accounts filed

fiscal year 2023 · abbreviated schema · 26 days late

Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors

no sitting director, no change since 2026

We have established no sitting directors for this company. We derive directors from published Gazette acts; while there are none, or none read, nothing appears here. That does not mean the company has none: the CBE keeps its own list of function holders, which we do not read.

13-02-2026 Resigned as Managing director

Location & real-estate footprint

Registered office, Brussel · 1 establishment unit since 2022

establishment The establishment unit on the map

Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Zavelput 171000 Brussel

Ground area

212 m²

Building footprint

172 m²

Volume, LiDAR